日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study

基于 Ki67 状态的 II-III 期乳腺癌新辅助内分泌治疗(序贯帕博西尼联合化疗):一项开放标签的 II 期研究

Engebrethsen, Christina; Yndestad, Synnøve; Rasmussen, Mari E; Janssen, Emiel A M; Gilje, Bjørnar; Blix, Egil S; Espelid, Helge; Lundgren, Steinar; Geisler, Jürgen; Minsaas, Laura; Lillestøl, Reidun; Aase, Hildegunn S; Aas, Turid; Lønning, Per E; Eikesdal, Hans P; Knappskog, Stian

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development

产前BRCA1表观遗传突变对三阴性乳腺癌的发生发展有显著影响。

Nikolaienko, Oleksii; Eikesdal, Hans P; Ognedal, Elisabet; Gilje, Bjørnar; Lundgren, Steinar; Blix, Egil S; Espelid, Helge; Geisler, Jürgen; Geisler, Stephanie; Janssen, Emiel A M; Yndestad, Synnøve; Minsaas, Laura; Leirvaag, Beryl; Lillestøl, Reidun; Knappskog, Stian; Lønning, Per E

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

原发性乳腺癌各亚型中同源重组缺陷

Yndestad, Synnøve; Engebrethsen, Christina; Herencia-Ropero, Andrea; Nikolaienko, Oleksii; Vintermyr, Olav K; Lillestøl, Reidun K; Minsaas, Laura; Leirvaag, Beryl; Iversen, Gjertrud T; Gilje, Bjørnar; Blix, Egil S; Espelid, Helge; Lundgren, Steinar; Geisler, Jürgen; Aase, Hildegunn S; Aas, Turid; Gudlaugsson, Einar G; Llop-Guevara, Alba; Serra, Violeta; Janssen, Emiel A M; Lønning, Per E; Knappskog, Stian; Eikesdal, Hans P

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer

BRCA1基因甲基化与三阴性乳腺癌和高级别浆液性卵巢癌的发生风险

Lønning, Per E; Nikolaienko, Oleksii; Pan, Kathy; Kurian, Allison W; Eikesdal, Hans P; Pettinger, Mary; Anderson, Garnet L; Prentice, Ross L; Chlebowski, Rowan T; Knappskog, Stian

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

原发性乳腺癌在序贯表柔比星和多西他赛单药治疗下的克隆演变

Venizelos, Andreas; Engebrethsen, Christina; Deng, Wei; Geisler, Jürgen; Geisler, Stephanie; Iversen, Gjertrud T; Aas, Turid; Aase, Hildegunn S; Seyedzadeh, Manouchehr; Steinskog, Eli Sihn; Myklebost, Ola; Nakken, Sigve; Vodak, Daniel; Hovig, Eivind; Meza-Zepeda, Leonardo A; Lønning, Per E; Knappskog, Stian; Eikesdal, Hans P

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

从临床基因组测序中检测到的突变特征3与乳腺癌和卵巢癌对奥拉帕尼的反应相关

Batalini, Felipe; Gulhan, Doga C; Mao, Victor; Tran, Antuan; Polak, Madeline; Xiong, Niya; Tayob, Nabihah; Tung, Nadine M; Winer, Eric P; Mayer, Erica L; Knappskog, Stian; Lønning, Per E; Matulonis, Ursula A; Konstantinopoulos, Panagiotis A; Solit, David B; Won, Helen; Eikesdal, Hans P; Park, Peter J; Wulf, Gerburg M

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

PARP抑制剂可将巨噬细胞重编程为抗肿瘤表型

Lin Wang ,Dan Wang ,Olmo Sonzogni ,Shizhong Ke ,Qi Wang ,Abhishek Thavamani ,Felipe Batalini ,Sylwia A Stopka ,Michael S Regan ,Steven Vandal ,Shengya Tian ,Jocelin Pinto ,Andrew M Cyr ,Vanessa C Bret-Mounet ,Gerard Baquer ,Hans P Eikesdal ,Min Yuan ,John M Asara ,Yujing J Heng ,Peter Bai ,Nathalie Y R Agar ,Gerburg M Wulf

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

新辅助化疗引起的 DNA 甲基化变化与乳腺癌生存相关

Christine Aaserød Pedersen #, Maria Dung Cao #, Thomas Fleischer, Morten B Rye, Stian Knappskog, Hans Petter Eikesdal, Per Eystein Lønning, Jörg Tost, Vessela N Kristensen, May-Britt Tessem, Guro F Giskeødegård, Tone F Bathen

An Ultrasensitive Routine LC-MS/MS Method for Estradiol and Estrone in the Clinically Relevant Sub-Picomolar Range

一种用于检测临床相关亚皮摩尔浓度范围内雌二醇和雌酮的超灵敏常规液相色谱-串联质谱方法

Bertelsen, Bjørn-Erik; Kellmann, Ralf; Viste, Kristin; Bjørnevik, Anne Turid; Eikesdal, Hans Petter; Lønning, Per Eystein; Sagen, Jørn V; Almås, Bjørg

Constitutional Mosaic Epimutations - a hidden cause of cancer?

体质嵌合表观突变——癌症的隐性病因?

Lønning, Per E; Eikesdal, Hans P; Løes, Inger M; Knappskog, Stian